Week In Review: Sino Biological Stages $772 Million IPO On ChiNext Exchange

Sino Biological​​​, a Beijing company that offers biological research reagents to global markets, completed a $772 million IPO on Shenzhen's ChiNext Exchange. On the first day of trading, the stock closed 68% higher at a market cap of $5.2 billion.